822 results on '"Antibodies -- Health aspects -- Research"'
Search Results
352. Studies in the Area of Bordetella pertussis Reported from University of Texas (Antibodies Binding Diverse Pertactin Epitopes Protect Mice From Bordetella Pertussis Infection)
353. Research Conducted at Johns Hopkins University Has Provided New Information about HIV/AIDS (Tcr-mimic Bispecific Antibodies To Target the Hiv-1 Reservoir)
354. Report Summarizes COVID-19 Study Findings from Department of Internal Medicine (Flipped Inflammatory Time and the Role of Antibodies Against Severe Acute Respiratory Syndrome Coronavirus 2: Optimizing Tocilizumab Against Coronavirus Disease 2019)
355. Centers for Disease Control and Prevention Reports Findings in COVID-19 [Serologic Testing of Us Blood Donations To Identify Severe Acute Respiratory Syndrome Coronavirus 2 (Sars-cov-2)-reactive Antibodies: December 2019-january 2020]
356. Reports from University of Leipzig Add New Data to Findings in COVID-19 (Antibody Course and Memory B-cell Response In the First Year After Severe Acute Respiratory Syndrome Coronavirus 2 Infection)
357. Investigators at Seoul National University Describe Findings in COVID-19 (Persistent Antibody Responses Up To 18 Months After Mild Severe Acute Respiratory Syndrome Coronavirus 2 Infection)
358. Study Results from Westlake University Provide New Insights into Biosensors (Rapid Biosensing Sars-cov-2 Antibodies In Vaccinated Healthy Donors)
359. Researchers from Capital Medical University Describe Findings in Dengue Hemorrhagic Fever (Seroepidemiologic Study On Convalescent Sera From Dengue Fever Patients In Jinghong, Yunnan)
360. New siRNA-Based Therapy Findings from Nanjing University Outlined (A Photoresponsive Antibody-sirna Conjugate for Activatable Immunogene Therapy of Cancer)
361. Findings from Ministry of Health Broaden Understanding of COVID-19 (Hybrid Proteins With Short Conformational Epitopes of the Receptor-binding Domain of Sars-cov-2 Spike Protein Promote Production of Virus-neutralizing Antibodies When Used for ...)
362. Hema-Quebec Details Findings in COVID-19 (Seroprevalence of Sars-cov-2 Antibodies Among Blood Donors In Quebec: an Update From a Serial Cross-sectional Study)
363. New Findings on COVID-19 from University of Texas San Antonio Summarized (Isotyping and Quantitation of the Humoral Immune Response To Sars-cov-2)
364. Findings on U.S. Military Research Reported by Investigators at U.S. Military HIV Research Program (Hiv-1 Infections With Multiple Founders Associate With the Development of Neutralization Breadth)
365. New Findings on COVID-19 Described by Investigators at University Hospital Heidelberg (Microscopy-based Assay for Semi-quantitative Detection of Sars-cov-2 Specific Antibodies In Human Sera a Semi-quantitative, High Throughput, Microscopy-based ...)
366. New COVID-19 Findings Has Been Reported by Investigators at Saint Luc University Clinic (Clinical Usefulness of Fully Automated Chemiluminescent Immunoassay for Quantitative Antibody Measurements In Covid-19 Patients)
367. Reports on Liver Cancer Findings from University of Missouri Provide New Insights (Nanoliposome C6-ceramide In Combination With Anti-ctla4 Antibody Improves Anti-tumor Immunity In Hepatocellular Cancer)
368. New COVID-19 Findings from Mayo Clinic Described (Low Antispike Antibody Levels Correlate With Poor Outcomes In Covid-19 Breakthrough Hospitalizations)
369. Study suggests COVID-19 Omicron variant infection induces limited immune response
370. COVID-19 booster essential, even among individuals previously infected
371. Researchers from University of Texas Southwestern Medical Center Dallas Detail New Studies and Findings in the Area of Hepatitis C Virus (Hepatitis C Epidemiology In a Large Urban Jail: a Changing Demographic)
372. New HIV/AIDS Findings from University of California San Francisco (UCSF) Outlined (First-in-human Immunopet Imaging of Hiv-1 Infection Using Zr-89-labeled Vrc01 Broadly Neutralizing Antibody)
373. Recent Findings in COVID-19 Described by Researchers from Sungkyunkwan University (Clinical Application of Rapid Diagnostic Test Kit for Sars-cov-2 Antibodies Into the Field of Patient Care)
374. New COVID-19 Study Findings Have Been Reported from Donald and Barbara Zucker School of Medicine at Hofstra Northwell (Passive Transfer of Sars-cov-2 Antibodies With Platelet Transfusions)
375. Findings in COVID-19 Reported from University of Regensburg (A Highly Specific and Sensitive Serological Assay Detects Sars-cov-2 Antibody Levels In Covid-19 Patients That Correlate With Neutralization)
376. Findings from University Clinical Hospital Mostar in the Area of COVID-19 Described (Sustained Seroprevalence of Sars-cov-2 Antibodies 1 Year After Infection: One of the First Covid-19 Cluster Cases In Bosnia and Herzegovina)
377. Showa University Reports Findings in Lung Diseases and Conditions (Anti-mda-5 Antibody-positive Clinically Amyopathic Dermatomyositis With Rapidly Progressive Interstitial Lung Disease Treated With Therapeutic Plasma Exchange: a Case Series)
378. Reports Outline COVID-19 Study Findings from Southern University of Science and Technology (SUSTech) (Antibody Responses To Sars-cov-2 In Healthy Individuals Returning To Shenzhen)
379. New Severe Acute Respiratory Syndrome Findings from Northwestern University Described (Low Levels of Neutralizing Antibodies After Natural Infection With Severe Acute Respiratory Syndrome Coronavirus 2 In a Community-based Serological Study)
380. New COVID-19 Study Findings Recently Were Reported by Researchers at Charite University Hospital and School of Medicine (Sars-cov-2 Beta Variant Infection Elicits Potent Lineage-specific and Cross-reactive Antibodies)
381. New Research at the 2021 AACC Annual Scientific Meeting Captures SARS-CoV-2 Antibody Patterns in Vaccinated and Naturally Infected Individuals
382. NEW RESEARCH AT THE 2021 AACC ANNUAL SCIENTIFIC MEETING CAPTURES SARS-COV-2 ANTIBODY PATTERNS IN VACCINATED AND NATURALLY INFECTED INDIVIDUALS
383. New Research at the 2021 AACC Annual Scientific Meeting Captures SARS-CoV-2 Antibody Patterns in Vaccinated and Naturally Infected Individuals
384. Antibodies to Early Strains of COVID May Not Fight New Variants: Study
385. Chile : Research shows the behavior of antibodies against SARS-CoV-2 in population vaccinated with Sinovac and Pfizer-BioNTech in Chile
386. Antibodies from original strain COVID-19 infection don't bind to variants: study
387. University researchers discover llama nanobodies as possible COVID-19 treatment
388. Increased infectivity, ability to escape immunity drove Delta variant: Study
389. Argentina : Argentine study confirms the increasing potency of neutralizing antibodies 6 months after the application of Sputnik V
390. Prior COVID Infection Doesn't Guarantee Good Immunity: Study
391. Longer, Worse COVID Leaves Stronger Antibodies: Study
392. IMMUNE RESPONSE TO COVID-19 MAY BE PROPORTIONAL TO ILLNESS SEVERITY, DURATION
393. SHARED ANTIBODIES MAY PUSH COVID VARIANTS:'eSTUDY
394. Study in China finds Covid-19 antibodies last at least 12 months
395. S-protein Antibody Against SARS CoV2 Lasts Till 4-months: ICMR Study
396. Antibody response to diphtheria-tetanus-pertussis immunization in preterm infants who receive dexamethasone for chronic lung disease
397. Canadian researchers discover 'spider web' mechanism that can trap, kill viruses
398. VIRUS THAT CAUSES COVID-19 CAN FIND ALTERNATE ROUTE TO INFECT CELLS
399. Dual-antibody combination therapies effective against SARS-CoV-2 variants in animal study
400. ENGINEERING NANOBODIES AS LIFESAVERS WHEN SARS-COV-2 VARIANTS ATTACK
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.